{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-007130","form_type":"8-K","ticker":"UFPT","cik":"0000914156","company_name":"UFP TECHNOLOGIES INC","filed_at":"2022-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.021969+00:00","generated_at":"2026-06-22T07:29:31.628037+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"UFP Technologies reports record Q3: EPS $2.56 vs $0.50, sales up 91% to $97M","bullets":["Net income $19.5M ($2.56 diluted EPS) vs $3.8M ($0.50) in Q3 2021; sales $97.0M, up 91.2% YoY.","Medical market sales surged 152% to $81.6M; organic sales grew 21.7%, organic operating income up 36.6%.","Results include $15.6M gain on sale of Molded Fiber Technology and $3.3M earnout charge for DAS acquisition.","Gross margin improved to 26.3% from 23.7%; year-to-date net income $33.3M, up from $12.7M."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-007130","json":"https://secwatch.observer/filing/0001171843-22-007130.json","markdown":"https://secwatch.observer/filing/0001171843-22-007130.md","text":"https://secwatch.observer/filing/0001171843-22-007130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914156/000117184322007130/0001171843-22-007130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914156/000117184322007130/f8k_110422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:29:31.628037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fcf9323f7248980e715df49793c4435649e80b4","claim":"UFP TECHNOLOGIES INC reported nine-month period ended September 30, 2022 results: revenue $262.6 million, net income $33.3 million, EPS $4.37 per diluted common share outstanding.","evidence_excerpt":"Net income for the nine-month period ended September 30, 2022 was $33.3 million or $4.37 per diluted common share outstanding compared to $12.7 million or $1.67 per diluted common share outstanding for the same period in 2021. Sales for the nine-month period ended September 30, 2022 were $262.6 million compared to sales of $150.0 million for the same period in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914156/000117184322007130/0001171843-22-007130-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine-month period ended September 30, 2022"},{"label":"Revenue","value":"$262.6 million"},{"label":"Net income","value":"$33.3 million"},{"label":"EPS","value":"$4.37 per diluted common share outstanding"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e25e19c8d11c774ad2ad98a899f7feb6ad14f2f8","claim":"UFP TECHNOLOGIES INC reported third quarter ended September 30, 2022 results: revenue $97.0 million, net income $19.5 million, EPS $2.56 per diluted common share outstanding.","evidence_excerpt":"UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $19.5 million or $2.56 per diluted common share outstanding for its third quarter ended September 30, 2022, compared to net income of $3.8 million or $0.50 per diluted common share outstanding for the same quarter in 2021. Sales for the third quarter were $97.0 million compared to 2021 third quarter sales of $50.7 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914156/000117184322007130/0001171843-22-007130-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$97.0 million"},{"label":"Net income","value":"$19.5 million"},{"label":"EPS","value":"$2.56 per diluted common share outstanding"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}